C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2713753
Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase.
Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (LBD) du cerveau dun patient. Les inhibiteurs de PLK2 kinase constituent des agents préférés.
Anderson John P.
Basi Guriqbal S.
Chereau David
Chilcote Tamie J.
Frigon Normand L. Jr.
Elan Pharma International Limited
Fetherstonhaugh & Co.
LandOfFree
Alpha-synuclein kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-synuclein kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-synuclein kinase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1483114